FindTrial
Sign In

The correlation between homocysteine and metabolic associated fatty liver disease

The correlation between homocysteine and metabolic associated fatty liver disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100051
Enrollment
Unknown
Registered
2025-04-02
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic-associated fatty liver disease

Interventions

metabolic-associated fatty liver disease group:NA
control group:NA

Sponsors

The Seventh Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. ages 18 and older; 2. the Han nationality; 3. data acquisition complete.

Exclusion criteria

Exclusion criteria: 1. psychotic patients; 2. Patients with severe cognitive or neurological deficits; 3. Patients with severe organic lesions; 4. Patients with serious liver and kidney dysfunction; 5. incomplete date;

Design outcomes

Primary

MeasureTime frame
homocysteine;Color Doppler ultrasound results of liver, gallbladder, pancreas, and spleen;—

Secondary

MeasureTime frame
Body mass index;waist circumference;hip circumference;blood pressure;glucose metabolism index;lipid metabolism index;liver/ kidney function index;—

Countries

China

Contacts

Public ContactChen Jiayu

The Seventh Affiliated Hospital of Southern Medical University

348306043@qq.com+86 757 85631019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026